ITGRHealthcare · Medical DevicesThe 9 Wall Street analysts covering Integer Holdings Corp. hold a median 12-month price target of $127 — +0.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 77 of 100 as at 14 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Integer Holdings Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (92): The share price has been relatively steady.
Accruals (48): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (24): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ITGR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +0.3% from it.
Of the 20 most recent actions, 3 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 14 Aug 2026 | Benchmark | Downgrade | Hold | — |
| 4 Aug 2026 | Freedom Capital Markets | Downgrade | Hold | — |
| 4 Aug 2026 | Freedom Capital Markets | Downgrade | Hold | — |
| 4 Aug 2026 | Oppenheimer | Downgrade | Perform | — |
| 4 Aug 2026 | Oppenheimer | Downgrade | Perform | — |
| 4 Aug 2026 | Truist Securities | Downgrade | Hold | — |
| 4 Aug 2026 | Truist Securities | Downgrade | Hold | $110 → $127 |
| 4 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | $84 → $127 |
| 4 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 3 Aug 2026 | Keybanc | Downgrade | Sector Weight | — |
| 3 Aug 2026 | Keybanc | Downgrade | Sector Weight | — |
| 22 July 2026 | Freedom Capital Markets | Initiates | Buy | $112 |
| 22 July 2026 | Freedom Capital Markets | Initiates | Buy | — |
| 16 July 2026 | Truist Securities | Maintains | Buy | $97 → $110 |
| 16 July 2026 | Truist Securities | Maintains | Buy | — |
| 8 July 2026 | Citigroup | Maintains | Neutral | — |
| 28 May 2026 | Citigroup | Maintains | Neutral | — |
| 13 May 2026 | Oppenheimer | Upgrade | Outperform | — |
| 1 May 2026 | Citigroup | Maintains | Neutral | — |
| 1 May 2026 | Piper Sandler | Reiterates | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ITGR appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, Integer Holdings Corp. returned +21.8% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 22% of US stocks
Cheaper than 48% of US stocks
Cheaper than 36% of US stocks
Cheaper than 20% of US stocks
Higher than 23% of US stocks
Higher than 14% of US stocks
Higher than 26% of US stocks
Higher than 64% of US stocks
Higher than 64% of US stocks
Higher than 58% of US stocks
Higher than 70% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Integer Holdings Corp. has a market value of $4.3B and an enterprise value of $5.6B.
Revenue in the twelve months to 30 June 2026: $1.8B. The latest quarter shrank 2.6% year on year.
Net income over the same four quarters: $128.4M, a 7.0% net margin.
Diluted earnings per share, trailing twelve months: $3.66.
Free cash flow in the twelve months to 30 June 2026: $112.0M.
Trailing P/E: 34.6×; forward P/E: 18.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Integer Holdings Corp. employs 11,000 people — $168K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Integer Holdings Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research reports that recent movements in the options market have drawn attention to Integer Holdings (ITGR). The headline asks whether the options market is predicting a spike in the stock.
Why it matters — ITGR watchers may want to note the reported options-market activity and the question it raises about the stock.
Integer Holdings Corporation notified holders of its 2.125% Convertible Senior Notes due 2028 that the notes are convertible at the holders' option beginning October 1, 2026, through December 31, 2026. The notes convert into cash, shares of common stock, or a combination thereof for amounts above the principal.
Why it matters — ITGR watchers would care because this conversion window may lead to changes in the company's share count and capital structure during the specified period.
Zacks Investment Research published a comparison of Globus Medical (GMED) and Integer (ITGR), two medical instruments stocks, to assess which offers value investors better returns currently. The piece frames both companies for investors familiar with the sector.
Why it matters — This comparison highlights how Integer is positioned against a peer, which is useful context for investors tracking ITGR's relative valuation.
Integer Holdings announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has been terminated early in connection with its previously announced acquisition by an affiliate of investment funds managed by KKR.
Why it matters — The early termination clears a key regulatory step, bringing the pending KKR acquisition of Integer closer to completion.
Zacks notes that Integer Holdings' $127-per-share deal with KKR provides defined cash value for shareholders. However, the company's core franchises are experiencing slow adoption of new products.
Why it matters — ITGR watchers would care because the article weighs the certain cash value from the KKR transaction against slower new-product adoption in the company's core businesses, offering a view of the stock's current position.
The 9 Wall Street analysts covering Integer Holdings Corp. have a median 12-month price target of $127, with estimates ranging from $101 to $127. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering Integer Holdings Corp., 0 rate it a Buy, 9 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Integer Holdings Corp. 77 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 14 Oct 2026, Integer Holdings Corp. ranks 77 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (92 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies +0.3% from the last close, and Ticker Nerd's factor model ranks Integer Holdings Corp. 77 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Integer Holdings Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ITGR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $101 to $127 over the next 12 months.
Integer Holdings Corp. returned +21.8% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Integer Holdings Corporation is a medical device contract development and manufacturing company that provides outsourced design, development, and production solutions for original equipment manufacturers. Integer Holdings Corporation serves key healthcare markets including cardio and vascular, cardiac rhythm management, and neuromodulation, supplying components, subassemblies, and finished devices used in interventional procedures and implantable therapies.
The most recent item we track (Zacks Investment Research, 7 Oct 2026): "Is the Options Market Predicting a Spike in Integer Holdings Stock?". Zacks Investment Research reports that recent movements in the options market have drawn attention to Integer Holdings (ITGR). The headline asks whether the options market is predicting a spike in the stock.
Integer Holdings Corporation is a medical device contract development and manufacturing company that provides outsourced design, development, and production solutions for original equipment manufacturers. Integer Holdings Corporation serves key healthcare markets including cardio and vascular, cardiac rhythm management, and neuromodulation, supplying components, subassemblies, and finished devices used in interventional procedures and implantable therapies. Its portfolio includes technologies for cardiovascular care, electrophysiology, structural heart applications, and other specialized medical applications, along with selected non-medical power solutions. The company plays an important role in the medical technology supply chain by helping device makers bring complex products to market with specialized engineering and manufacturing capabilities. Headquartered in Plano, Texas, Integer Holdings Corporation focuses on supporting established healthcare and life science customers across global markets.
CEO Mr. Payman Khales · 11,000 employees · United States · https://www.integer.net
